Abiopharma

🔍 Kalajian Tony T (Executive)

Company: BEYOND MEAT, INC. (BYND)

Report Date: 2026-05-10

Detailed Transactions and Holdings:

• Acquired 180,051 shares of Common Stock (Direct)
  Date: 2026-05-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 180,051.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 237,718 shares of Stock Option (right to buy) at $0.8331 per share (Derivative)
  Date: 2026-05-10 | Code: A | Expires: 2036-05-09 | equity_swap_involved: 0 | shares_owned_after: 237,718.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: RSUs granted under the 2026 Employment Inducement Equity Incentive Plan ("Plan") on May 10, 2026; 1/4th of the total number of shares subject to the RSU award vests on January 12, 2027, and 1/16th of the total number of shares subject to the RSU award vests each quarter thereafter, until the award is fully vested on January 12, 2030, subject to the acceleration provisions of an Executive Change in Control Severance Agreement by and between the Reporting Person and the Issuer, and continued service by the Reporting Person.
• F2: Stock option granted under the Plan on May 10, 2026; 1/4th of the total number of shares subject to the option award vests and becomes exercisable on January 12, 2027, and 1/48th of the total number of shares subject to the option award vests and becomes exercisable monthly thereafter, such that the option becomes fully vested and exercisable on January 12, 2030, subject to the acceleration provisions of an Executive Change in Control Severance Agreement by and between the Reporting Person and the Issuer, and continued service by the Reporting Person.